This is the authors' abstract. We don't add key points for this paper.
Using mouse genetics, we recently showed that BRAF has a critical role in initiation of NRAS-driven melanoma that cannot be compensated by CRAF. In contrast, RAF proteins display compensatory functions in fully established tumors and ARAF can sustain proliferation in the absence of BRAF and CRAF, highlighting an addiction to RAF signaling in NRAS-driven melanoma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Druillennec et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: